Wanbury Limited (NSE:WANBURY) — Market Cap & Net Worth
Market Cap & Net Worth: Wanbury Limited (WANBURY)
Wanbury Limited (NSE:WANBURY) has a market capitalization of $98.79 Million (Rs9.13 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #19311 globally and #1039 in its home market, demonstrating a 0.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Wanbury Limited's stock price Rs261.45 by its total outstanding shares 34939398 (34.94 Million). Review WANBURY liabilities breakdown to assess the company's total debt and financial obligations.
Wanbury Limited Market Cap History: 2015 to 2026
Wanbury Limited's market capitalization history from 2015 to 2026. Data shows growth from $34.74 Million to $98.79 Million (13.83% CAGR).
Wanbury Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Wanbury Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Wanbury Limited's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.28x
Wanbury Limited's market cap is 0.28 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $23.28 Million | $4.23 Billion | -$71.46 Million | 0.01x | N/A |
| 2017 | $16.78 Million | $4.29 Billion | $620.15 Million | 0.00x | 0.03x |
| 2018 | $7.69 Million | $3.68 Billion | -$320.08 Million | 0.00x | N/A |
| 2019 | $7.03 Million | $3.87 Billion | -$248.48 Million | 0.00x | N/A |
| 2020 | $17.63 Million | $3.63 Billion | $644.62 Million | 0.00x | 0.03x |
| 2021 | $31.87 Million | $3.87 Billion | -$126.06 Million | 0.01x | N/A |
| 2022 | $18.51 Million | $5.11 Billion | $814.74 Million | 0.00x | 0.02x |
| 2023 | $47.63 Million | $4.98 Billion | -$103.96 Million | 0.01x | N/A |
| 2024 | $110.02 Million | $5.74 Billion | $559.56 Million | 0.02x | 0.20x |
| 2025 | $85.62 Million | $6.00 Billion | $305.30 Million | 0.01x | 0.28x |
Competitor Companies of WANBURY by Market Capitalization
Companies near Wanbury Limited in the global market cap rankings as of June 19, 2026.
Key companies related to Wanbury Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Wanbury Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Wanbury Limited's market cap moved from $34.74 Million to $ 98.79 Million, with a yearly change of 13.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs98.79 Million | +15.38% |
| 2025 | Rs85.62 Million | -22.18% |
| 2024 | Rs110.02 Million | +131.00% |
| 2023 | Rs47.63 Million | +157.24% |
| 2022 | Rs18.51 Million | -41.91% |
| 2021 | Rs31.87 Million | +80.81% |
| 2020 | Rs17.63 Million | +150.81% |
| 2019 | Rs7.03 Million | -8.60% |
| 2018 | Rs7.69 Million | -54.17% |
| 2017 | Rs16.78 Million | -27.92% |
| 2016 | Rs23.28 Million | -33.01% |
| 2015 | Rs34.74 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Wanbury Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $98.79 Million USD |
| MoneyControl | $98.79 Million USD |
| MarketWatch | $98.79 Million USD |
| marketcap.company | $98.79 Million USD |
| Reuters | $98.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more